Synthesis and antimicrobial activity of new pyridine-based half-sandwich Ru(II) complexes

Tamara A. PetrovićMarija V. DimitrijevićLjiljana E. Mihajlović-LalićDalibor StankovićFilip VlahovićSanja Grgurić-ŠipkaTatjana M. Mihajilov-KrstevDragoljub L. MiladinovićJelena M. Poljarevića University of Belgrade - Faculty of Chemistry,Belgrade,Serbiab Department of Pharmacy,Faculty of Medicine,University of Niš,Niš,Serbiac Innovative Centre of the Faculty of Chemistry Belgrade,Belgrade,Serbiad Institute of Chemistry,Technology and Metallurgy – National Institute of the Republic of Serbia,University of Belgrade,Belgrade,Serbiae Department of Biology and Ecology,Faculty of Science and Mathematics,University of Niš,Niš,Serbia

DOI: https://doi.org/10.1080/00958972.2024.2307911

2024-02-10

Journal of Coordination Chemistry

Abstract:Eight new ruthenium complexes ( C1 , C2 (Ru-benzene or Ru-toluene complexes with L1 , 3-amino-2-chloropyridine); C3 , C4 (Ru-benzene or Ru-toluene complexes with L2 , 2-amino-5-chloropyridine); C5 , C6 (Ru-benzene or Ru-toluene complexes with L3 , 3-acetylpyridine); and C7 , C8 (Ru-benzene or Ru-toluene complexes with L4 , 4-acetylpyridine) were synthesized. The chemical structures and purity of the compounds were confirmed using standard analytical methods such as 1 H, 13 C NMR and IR spectroscopy, mass spectrometry, and elemental analysis, and their electrochemical behavior was evaluated using cyclic voltammetry experiments. The stability of the compounds in dimethyl sulfoxide solution was confirmed using 1 H NMR spectroscopy. Finally, the antimicrobial potential of two complex precursors ( CP1 , [Ru(η 6 -benzene)Cl( μ -Cl)] 2 and CP2 , [Ru(η 6 -toluene)Cl( μ -Cl)] 2 ), four ligands ( L1 – L4 ), and eight corresponding complexes ( C1 – C8 ) was screened against nine pathogenic microorganisms and two reference bacterial strains using the micro-well dilution method. The highest antibacterial activity (0.63 mg/mL) was for C5 against Staphylococcus aureus , Bacillus cereus , Escherichia coli , and Salmonella enteritidis , while C8 displayed more pronounced antimicrobial activity against Candida albicans (MIC/MMC = 0.31 mg/mL). Subsequently, the studied complexes underwent a detailed examination utilizing the DFT methodology, acquiring important quantum-chemical descriptors. Notably, the HOMO-LUMO gap was established as a significant correlate with the antimicrobial activity of synthesized compounds.

chemistry, inorganic & nuclear

What problem does this paper attempt to address?

Synthesis and antimicrobial activity of new pyridine-based half-sandwich Ru(II) complexes

Synthesis and antibacterial against S. aureus of new ruthenium (II) polypyridine complexes containing pyrene groups

Exploring the potential of highly charged Ru(II)- and heteronuclear Ru(II)/Cu(II)-polypyridyl complexes as antimicrobial agents

In vitro evaluation of novel Ru (II) complexes of thiazolhidrazinylidene-chroman-2,4-diones for their potential antibacterial activity

Synthesis, Spectroscopic, Antioxidant, and Antibacterial Investigations

Ruthenium Complexes with Pyridazine Carboxylic Acid: Synthesis, Characterization, and Anti-Biofilm Activity

Ru(II)‐Nitrophenylhydrazine/Chlorophenylhydrazine Complexes: Nanoarchitectonics, Biological Evaluation and In silico Study

Novel half-sandwich ruthenium(II) nicotinic hydrazone complexes: An efficient class of catalyst for the N-alkylation of amines with benzyl alcohol via transfer hydrogen mechanism and effective antibacterial agents

Anticancer and antimicrobial properties of novel η6- p-cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization

Fortuitous synthesis of unsaturated half-sandwich Ruthenium(II) complexes via solvent-involved rearrangement and their biological evaluation

Ruthenium polypyridine complexes containing prenyl groups as antibacterial agents against Staphylococcus aureus through a membrane‐disruption mechanism

In silico and in vitro biological evaluation: distribution of Ru(III) Schiff base complexes through the pancreatic 3D model and immersed blood vessel network

Half‐sandwich ruthenium(II) and iridium(III) complexes of imidazole based phosphinite ligands: antioxidant and antibacterial activities as well as electrochemical properties

Antibacterial and ct-DNA binding studies of new synthesized ruthenium (III) hydroxamate complexes: Design, synthesis, DFT calculations and in-vitro study

Synthesis, characterisation and biological activity of the ruthenium(II) complexes of the N4-tetradentate (N4-TL), 1,6-di(2′-pyridyl)-2,5-dibenzyl-2,5-diazahexane (picenBz2)

Synthesis, Antitumor Activity and Structure–activity Relationships of a Series of Ru(II) Complexes

Synthesis, characterization, and anticancer activity of Ru( p -cymene) complexes bearing pyrazolyl–pyridine type ligands

Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline

Investigation of half-sandwich platinum group metal complexes featuring benzamide derived ligands and their diazido derivatives: Synthesis, molecular structures and biological studies

Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties

Syntheses, Characterization and Antitumor Activity of Three Mononuclear Ruthenium(II) Complexes